{"organizations": [], "uuid": "170090eacf1932cf5cf96c08a6f8051f25f1765f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/6", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/14/business-wire-tandem-diabetes-care-schedules-fourth-quarter-and-full-year-2017-earnings-press-release-and-conference-call.html", "country": "US", "domain_rank": 767, "title": "Tandem Diabetes Care Schedules Fourth Quarter and Full Year 2017 Earnings Press Release and Conference Call", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-15T00:15:00.000+02:00", "replies_count": 0, "uuid": "170090eacf1932cf5cf96c08a6f8051f25f1765f"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/14/business-wire-tandem-diabetes-care-schedules-fourth-quarter-and-full-year-2017-earnings-press-release-and-conference-call.html", "ord_in_thread": 0, "title": "Tandem Diabetes Care Schedules Fourth Quarter and Full Year 2017 Earnings Press Release and Conference Call", "locations": [], "entities": {"persons": [], "locations": [{"name": "san diego", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}], "organizations": [{"name": "pacific time", "sentiment": "none"}, {"name": "tandem diabetes care, inc", "sentiment": "none"}, {"name": "tandem diabetes care’s investor center", "sentiment": "none"}, {"name": "tandem diabetes care, inc.", "sentiment": "none"}, {"name": "eastern time", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its fourth quarter and full year 2017 results after the financial markets close on Thursday, March 1, 2018. The Company will hold a conference call and simultaneous webcast on the same day at 4:30pm Eastern Time (1:30pm Pacific Time), to discuss its fourth quarter and full year 2017 financial and operating results.\nConference Call/Webcast Details:\nDate: March 1, 2018\nTime: 4:30pm Eastern Time (1:30pm Pacific Time)\nToll Free Dial-In Number: (855) 427-4396\nInternational Dial-In Number: (484) 756-4261\nConference ID : 2489755\nWebcast Link: https://edge.media-server.com/m6/p/5m8s5kr7\nAn archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.\nAbout Tandem Diabetes Care, Inc.\nTandem Diabetes Care, Inc. ( www.tandemdiabetes.com ) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem manufactures and sells the t:slim X2™ Insulin Pump, the only pump capable of remote feature updates using a personal computer, now available with Dexcom G5® Mobile continuous glucose monitoring (CGM) integration, and the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements. Tandem is based in San Diego, California.\nFollow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, #tflex, #tconnect, and $TNDM.\nFollow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes .\nFollow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes .\nt:flex and Tandem Diabetes Care are registered trademarks, and t:slim X2 is a trademark of Tandem Diabetes Care, Inc. Dexcom G5 is a registered trademark of Dexcom, Inc.\nView source version on businesswire.com : http://www.businesswire.com/news/home/20180214006053/en/\nTandem Diabetes Care, Inc.\nMedia Contact:\nSteve Sabicer\n714-907-6264\nssabicer@thesabicergroup.com\nor\nInvestor Contact:\nSusan Morrison\n858-366-6900 x7005\nsmorrison@tandemdiabetes.com\nSource: Tandem Diabetes Care, Inc.", "external_links": ["https://edge.media-server.com/m6/p/5m8s5kr7", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.facebook.com%2FTandemDiabetes&esheet=51758887&newsitemid=20180214006053&lan=en-US&anchor=www.facebook.com%2FTandemDiabetes&index=4&md5=5b69aa8b148f0d532710a2ce4bc2937e", "http://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Flinkprotect.cudasvc.com%2Furl%3Fa%3Dhttps%3A%2F%2Fedge.media-server.com%2Fm6%2Fp%2F5m8s5kr7%26c%3DE%2C1%2C91izyaozZc_7TaUIWZVEcE_vnmEwIbkntjpoQBDXNjN3oRuatbDl4IYTrr230hpb3dK6Y9aURVsKJwmfhaz02AWqlJkStLdPjNIJCx8v5T5fDgR8kP2IBCbmbQ%2C%2C%26typo%3D1&esheet=51758887&newsitemid=20180214006053&lan=en-US&anchor=https%3A%2F%2Fedge.media-server.com%2Fm6%2Fp%2F5m8s5kr7&index=1&md5=9a8b8af7443e35d9885183c5abb312d4", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Finvestor.tandemdiabetes.com&esheet=51758887&newsitemid=20180214006053&lan=en-US&anchor=http%3A%2F%2Finvestor.tandemdiabetes.com&index=2&md5=28600f8325769ea5ba56d37dce64f116", "http://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ftandemdiabetes&esheet=51758887&newsitemid=20180214006053&lan=en-US&anchor=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ftandemdiabetes&index=5&md5=4e048e01772a8e4ed4aa25a31c833811", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.tandemdiabetes.com&esheet=51758887&newsitemid=20180214006053&lan=en-US&anchor=www.tandemdiabetes.com&index=3&md5=d12cd295851f9f12a6da14d7691ec6e4", "http://www.businesswire.com/news/home/20180214006053/en/", "https://www.linkedin.com/company/tandemdiabetes"], "published": "2018-02-15T00:15:00.000+02:00", "crawled": "2018-02-15T02:32:07.029+02:00", "highlightTitle": ""}